Figures & data
Figure 1. Final aggregation as measured by (A) light transmission aggregometry and (B) 96-well aggregometry in the presence of vehicle (white), aspirin (ASA, 30 μM; black), and AR-C66096 (AR-C, 1 μM; grey) in response to arachidonic acid (AA; 0.03–1 mM), ADP (0.005–40 μM, collagen (0.01–40 μg/ml), and U46619 (0.005–40 μM). Data were analyzed by one-way or two-way ANOVA and assessed as significant to *p < 0.05. N = 5 for each.
![Figure 1. Final aggregation as measured by (A) light transmission aggregometry and (B) 96-well aggregometry in the presence of vehicle (white), aspirin (ASA, 30 μM; black), and AR-C66096 (AR-C, 1 μM; grey) in response to arachidonic acid (AA; 0.03–1 mM), ADP (0.005–40 μM, collagen (0.01–40 μg/ml), and U46619 (0.005–40 μM). Data were analyzed by one-way or two-way ANOVA and assessed as significant to *p < 0.05. N = 5 for each.](/cms/asset/a3419c5f-9b67-4060-b4c7-1a9c66bfe230/iplt_a_1466388_f0001_b.gif)
Figure 2. Final aggregation in light transmission aggregometry with stir speeds of 100, 300, and 1200 rpm in the presence of vehicle (white), aspirin (ASA, 30 μM; black), and AR-C66096 (AR-C, 1 μM; grey) in response to (A) ADP (3 μM), (B) collagen (3 μg/ml), and (C) U46619 (3 μM). Data were analyzed by one-way ANOVA and assessed as significant to p < 0.05; * vs 100 rpm and $ vs vehicle. N = 5 for each.
![Figure 2. Final aggregation in light transmission aggregometry with stir speeds of 100, 300, and 1200 rpm in the presence of vehicle (white), aspirin (ASA, 30 μM; black), and AR-C66096 (AR-C, 1 μM; grey) in response to (A) ADP (3 μM), (B) collagen (3 μg/ml), and (C) U46619 (3 μM). Data were analyzed by one-way ANOVA and assessed as significant to p < 0.05; * vs 100 rpm and $ vs vehicle. N = 5 for each.](/cms/asset/a4a55746-29af-4c92-bc8d-8b8216069959/iplt_a_1466388_f0002_b.gif)